These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36151295)

  • 1. Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
    de Vries HD; Palmiotti A; Li R; Hovingh MV; Mulder NL; Koehorst M; Bloks VW; van Zutphen T; Kuipers F; de Boer JF
    Pediatr Res; 2023 May; 93(6):1582-1590. PubMed ID: 36151295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma bile acids coincide with cardiac stress and inflammation in young Cyp2c70
    de Vries HD; Eijgenraam TR; Bloks VW; Mulder NL; van Zutphen T; Silljé HHW; Kuipers F; de Boer JF
    Pediatr Res; 2024 Oct; ():. PubMed ID: 39358409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.
    de Boer JF; de Vries HD; Palmiotti A; Li R; Doestzada M; Hoogerland JA; Fu J; La Rose AM; Westerterp M; Mulder NL; Hovingh MV; Koehorst M; Kloosterhuis NJ; Wolters JC; Bloks VW; Haas JT; Dombrowicz D; Staels B; van de Sluis B; Kuipers F
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1045-1069. PubMed ID: 33309945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition.
    Li R; Hovingh MV; Koehorst M; de Blaauw P; Verkade HJ; de Boer JF; Kuipers F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159163. PubMed ID: 35470044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.
    Ueda H; Honda A; Miyazaki T; Morishita Y; Hirayama T; Iwamoto J; Nakamoto N; Ikegami T
    PLoS One; 2022; 17(7):e0271308. PubMed ID: 35819971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition.
    Sjöland W; Wahlström A; Makki K; Schöler M; Molinaro A; Olsson L; Greiner TU; Caesar R; de Boer JF; Kuipers F; Bäckhed F; Marschall HU
    Clin Sci (Lond); 2023 Jul; 137(13):995-1011. PubMed ID: 37384590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.
    Verkade E; Shen W; Hovingh MV; Mulder NL; de Bruyn K; Koehorst M; de Vries HD; Bloks VW; Kuipers F; de Boer JF
    Clin Sci (Lond); 2023 Nov; 137(21):1637-1650. PubMed ID: 37910096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice.
    Hasan MN; Chen J; Matye D; Wang H; Luo W; Gu L; Clayton YD; Du Y; Li T
    J Lipid Res; 2023 Mar; 64(3):100340. PubMed ID: 36737039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70
    Li R; Palmiotti A; de Vries HD; Hovingh MV; Koehorst M; Mulder NL; Zhang Y; Kats K; Bloks VW; Fu J; Verkade HJ; de Boer JF; Kuipers F
    J Lipid Res; 2021; 62():100134. PubMed ID: 34626589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
    Truong JK; Bennett AL; Klindt C; Donepudi AC; Malla SR; Pachura KJ; Zaufel A; Moustafa T; Dawson PA; Karpen SJ
    J Lipid Res; 2022 Sep; 63(9):100261. PubMed ID: 35934110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gly-β-MCA is a potent anti-cholestasis agent against "human-like" hydrophobic bile acid-induced biliary injury in mice.
    Hasan MN; Wang H; Luo W; Clayton YD; Gu L; Du Y; Palle SK; Chen J; Li T
    J Lipid Res; 2024 Oct; 65(10):100649. PubMed ID: 39306039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
    Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
    Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
    Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
    Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in
    Palmiotti A; de Vries HD; Hovingh MV; Koehorst M; Mulder NL; Verkade E; Veentjer MK; van Dijk TH; Bloks VW; Havinga R; Verkade HJ; de Boer JF; Kuipers F
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.